Literature DB >> 20168080

Structural basis of transmembrane domain interactions in integrin signaling.

Tobias S Ulmer1.   

Abstract

Cell surface receptors of the integrin family are pivotal to cell adhesion and migration. The activation state of heterodimeric alphabeta integrins is correlated to the association state of the single-pass alpha and beta transmembrane domains. The association of integrin alphaIIbbeta3 transmembrane domains, resulting in an inactive receptor, is characterized by the asymmetric arrangement of a straight (alphaIIb) and tilted (beta3) helix relative to the membrane in congruence to the dissociated structures. This allows for a continuous association interface centered on helix-helix glycine-packing and an unusual alphaIIb(GFF) structural motif that packs the conserved Phe-Phe residues against the beta3 transmembrane helix, enabling alphaIIb(D723)beta3(R995) electrostatic interactions. The transmembrane complex is further stabilized by the inactive ectodomain, thereby coupling its association state to the ectodomain conformation. In combination with recently determined structures of an inactive integrin ectodomain and an activating talin/beta complex that overlap with the alphabeta transmembrane complex, a comprehensive picture of integrin bi-directional transmembrane signaling has emerged.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20168080      PMCID: PMC2900621          DOI: 10.4161/cam.4.2.10592

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  55 in total

1.  Unambiguous prediction of human integrin transmembrane heterodimer interactions using only homologous sequences.

Authors:  Xin Lin; Suet Mien Tan; S K Alex Law; Jaume Torres
Journal:  Proteins       Date:  2006-11-01

2.  Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger.

Authors:  Eduard V Bocharov; Yulia E Pustovalova; Konstantin V Pavlov; Pavel E Volynsky; Marina V Goncharuk; Yaroslav S Ermolyuk; Dmitry V Karpunin; Alexey A Schulga; Michail P Kirpichnikov; Roman G Efremov; Innokenty V Maslennikov; Alexander S Arseniev
Journal:  J Biol Chem       Date:  2007-04-04       Impact factor: 5.157

Review 3.  Linking integrin conformation to function.

Authors:  Janet A Askari; Patrick A Buckley; A Paul Mould; Martin J Humphries
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

4.  Integrin alpha IIb beta 3 in a membrane environment remains the same height after Mn2+ activation when observed by cryoelectron tomography.

Authors:  Feng Ye; Jun Liu; Hanspeter Winkler; Kenneth A Taylor
Journal:  J Mol Biol       Date:  2008-03-14       Impact factor: 5.469

5.  Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering.

Authors:  Bing-Hao Luo; Christopher V Carman; Junichi Takagi; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits.

Authors:  A Armulik; I Nilsson; G von Heijne; S Johansson
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  Interactions of platelet integrin alphaIIb and beta3 transmembrane domains in mammalian cell membranes and their role in integrin activation.

Authors:  Chungho Kim; Tong-Lay Lau; Tobias S Ulmer; Mark H Ginsberg
Journal:  Blood       Date:  2009-02-13       Impact factor: 22.113

8.  Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?

Authors:  Andrew J Beel; Charles K Mobley; Hak Jun Kim; Fang Tian; Arina Hadziselimovic; Bing Jap; James H Prestegard; Charles R Sanders
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

9.  The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3.

Authors:  Jieqing Zhu; Bing-Hao Luo; Patrick Barth; Jack Schonbrun; David Baker; Timothy A Springer
Journal:  Mol Cell       Date:  2009-04-24       Impact factor: 17.970

10.  Determination of N- and C-terminal borders of the transmembrane domain of integrin subunits.

Authors:  Anne Stefansson; Annika Armulik; IngMarie Nilsson; Gunnar von Heijne; Staffan Johansson
Journal:  J Biol Chem       Date:  2004-03-10       Impact factor: 5.157

View more
  7 in total

1.  Annular anionic lipids stabilize the integrin αIIbβ3 transmembrane complex.

Authors:  Thomas Schmidt; Jae-Eun Suk; Feng Ye; Alan J Situ; Parichita Mazumder; Mark H Ginsberg; Tobias S Ulmer
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 2.  The tail of integrin activation.

Authors:  Nicholas J Anthis; Iain D Campbell
Journal:  Trends Biochem Sci       Date:  2011-01-06       Impact factor: 13.807

Review 3.  Integrins as Therapeutic Targets: Successes and Cancers.

Authors:  Sabine Raab-Westphal; John F Marshall; Simon L Goodman
Journal:  Cancers (Basel)       Date:  2017-08-23       Impact factor: 6.639

4.  αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.

Authors:  Sara Morais; Jorge Oliveira; Catarina Lau; Mónica Pereira; Marta Gonçalves; Catarina Monteiro; Ana Rita Gonçalves; Rui Matos; Marco Sampaio; Eugénia Cruz; Inês Freitas; Rosário Santos; Margarida Lima
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

5.  Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.

Authors:  Simon L Goodman; Hans Juergen Grote; Claudia Wilm
Journal:  Biol Open       Date:  2012-02-06       Impact factor: 2.422

6.  Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.

Authors:  Hirokazu Kashiwagi; Shinji Kunishima; Kazunobu Kiyomizu; Yoshiro Amano; Hiroyuki Shimada; Masashi Morishita; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Mol Genet Genomic Med       Date:  2013-04-22       Impact factor: 2.183

7.  Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.

Authors:  Laurent Jacob; Paul Sawma; Norbert Garnier; Lionel A T Meyer; Justine Fritz; Thomas Hussenet; Caroline Spenlé; Jacky Goetz; Julien Vermot; Aurore Fernandez; Nadège Baumlin; Samia Aci-Sèche; Gertraud Orend; Guy Roussel; Gérard Crémel; Monique Genest; Pierre Hubert; Dominique Bagnard
Journal:  Oncotarget       Date:  2016-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.